DE60329923D1 - Wachstumshormon freisetzende peptide - Google Patents
Wachstumshormon freisetzende peptideInfo
- Publication number
- DE60329923D1 DE60329923D1 DE60329923T DE60329923T DE60329923D1 DE 60329923 D1 DE60329923 D1 DE 60329923D1 DE 60329923 T DE60329923 T DE 60329923T DE 60329923 T DE60329923 T DE 60329923T DE 60329923 D1 DE60329923 D1 DE 60329923D1
- Authority
- DE
- Germany
- Prior art keywords
- growth hormone
- hormone releasing
- releasing peptides
- peptides
- growth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 101710119601 Growth hormone-releasing peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Reproductive Health (AREA)
- Crystallography & Structural Chemistry (AREA)
- Immunology (AREA)
- Pregnancy & Childbirth (AREA)
- Ophthalmology & Optometry (AREA)
- Neurology (AREA)
- Vascular Medicine (AREA)
- Gynecology & Obstetrics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40226302P | 2002-08-09 | 2002-08-09 | |
PCT/US2003/024834 WO2004014415A1 (en) | 2002-08-09 | 2003-08-08 | Growth hormone releasing peptides |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60329923D1 true DE60329923D1 (de) | 2009-12-17 |
Family
ID=31715820
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60329923T Expired - Lifetime DE60329923D1 (de) | 2002-08-09 | 2003-08-08 | Wachstumshormon freisetzende peptide |
Country Status (23)
Country | Link |
---|---|
US (7) | US7456253B2 (de) |
EP (2) | EP1542716B1 (de) |
JP (2) | JP4365319B2 (de) |
KR (1) | KR100967572B1 (de) |
CN (3) | CN102850436B (de) |
AR (2) | AR040965A1 (de) |
AT (1) | ATE447411T1 (de) |
AU (1) | AU2003259062B2 (de) |
BR (2) | BRPI0313273B8 (de) |
CA (1) | CA2494300C (de) |
CZ (1) | CZ20041254A3 (de) |
DE (1) | DE60329923D1 (de) |
DK (1) | DK1542716T3 (de) |
ES (1) | ES2334223T3 (de) |
HK (1) | HK1072908A1 (de) |
IL (1) | IL165998A (de) |
MX (1) | MXPA05000974A (de) |
NO (1) | NO20050205L (de) |
PL (1) | PL212138B1 (de) |
RU (2) | RU2323941C2 (de) |
SG (1) | SG177006A1 (de) |
TW (1) | TWI331922B (de) |
WO (1) | WO2004014415A1 (de) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI331922B (en) * | 2002-08-09 | 2010-10-21 | Ipsen Pharma Sas | Growth hormone releasing peptides |
MXPA05002991A (es) * | 2002-09-18 | 2005-10-05 | Univ Montreal Ct Hospitalier Chum | Analogos de ghrh. |
US20040186151A1 (en) * | 2003-02-12 | 2004-09-23 | Mjalli Adnan M.M. | Substituted azole derivatives as therapeutic agents |
WO2006045314A2 (en) * | 2004-10-27 | 2006-05-04 | Gastrotech Pharma A/S | Use of a growth hormone secretatogue for increasing or maintaining lean body mass and/or for treatment of chronic obstructive pulmonary disease |
JP2008521840A (ja) * | 2004-11-30 | 2008-06-26 | ガストロテック・ファルマ・アクティーゼルスカブ | 成長ホルモン分泌促進物質レセプター1aリガンド |
WO2007014258A2 (en) | 2005-07-22 | 2007-02-01 | Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. | Growth hormone secretagogues |
CA2625447C (en) * | 2005-09-29 | 2015-06-09 | Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. | Compositions and methods for stimulating gastrointestinal motility |
EP1818061A1 (de) * | 2005-12-02 | 2007-08-15 | Charite-Universitätsmedizin Berlin | Verwendung von Ghrelin zur Stimulierung des Haarwachstums |
CU23592A1 (es) * | 2006-02-28 | 2010-11-11 | Ct Ingenieria Genetica Biotech | Método para prevenir y eliminar las fibrosis y otras formas de depósito patológico en los tejidos aplicando el péptido secretagogo ghrp-6 |
EP2012809B1 (de) * | 2006-03-10 | 2013-05-22 | Ipsen Pharma | Verwendung eines ghrelin-agonisten zur erhöhung der katabolischen wirkung einer glukokortikoidbehandlung |
EP2021015A2 (de) * | 2006-04-28 | 2009-02-11 | The Administrators Of The Tulane Educational Fund | Ghrelin/ghrp/ghsr-antagonisten und ihre verwendung |
JP5134627B2 (ja) * | 2006-09-27 | 2013-01-30 | イプセン ファルマ ソシエテ パール アクシオン サンプリフィエ | N末端で置換されたグレリン類似体 |
JP5247678B2 (ja) | 2007-03-12 | 2013-07-24 | 雪印メグミルク株式会社 | 成長ホルモン分泌促進剤 |
TW200916113A (en) * | 2007-08-08 | 2009-04-16 | Sod Conseils Rech Applic | Method for inhibiting inflammation and pro-inflammatory cytokine/chemokine expression using a ghrelin analogue |
WO2009108364A2 (en) * | 2008-02-27 | 2009-09-03 | Ipsen Pharma S.A.S. | Antagonistic analogues of ghrh |
US9724381B2 (en) | 2009-05-12 | 2017-08-08 | The Administrators Of The Tulane Educational Fund | Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof |
KR101589191B1 (ko) * | 2010-03-15 | 2016-01-27 | 입센 파마 에스.에이.에스. | 성장 호르몬의 분비를 촉진시키는 수용체 리간드의 약학 조성물 |
JP6342808B2 (ja) * | 2011-10-18 | 2018-06-13 | エイルロン セラピューティクス,インコーポレイテッド | ペプチドミメティック大環状化合物 |
RU2625793C2 (ru) | 2011-12-23 | 2017-07-19 | Ипсен Мэньюфэкчеринг Айэлэнд Лимитед | Способ синтеза терапевтических пептидов |
US10039813B2 (en) | 2012-02-07 | 2018-08-07 | Massachusetts Institute Of Technology | Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness |
EP2705835A1 (de) * | 2012-06-08 | 2014-03-12 | Ipsen Pharma S.A.S. | Wässrige gelbildende Zusammensetzungen aus löslichen aktiven pharmazeutischen Peptiden, die eine modifizierte Freisetzung ermöglichen |
US9724396B2 (en) | 2013-03-15 | 2017-08-08 | Massachusetts Institute Of Technology | Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness |
US9119832B2 (en) | 2014-02-05 | 2015-09-01 | The Regents Of The University Of California | Methods of treating mild brain injury |
WO2015134567A1 (en) * | 2014-03-04 | 2015-09-11 | Rhythm Pharmaceuticals, Inc. | Process for the liquid phase synthesis of h-inp-(d)bal-(d)trp-phe-apc-nh2, and pharmaceutically acceptable salts thereof |
WO2016138099A1 (en) | 2015-02-24 | 2016-09-01 | Massachusetts Institute Of Technology | Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness |
US20170121385A1 (en) | 2015-10-28 | 2017-05-04 | Oxeia Biopharmaceuticals, Inc. | Methods of treating neurodegenerative conditions |
US10111929B1 (en) | 2017-04-07 | 2018-10-30 | Ez Ip, Llc | Growth hormone releasing factor analogs and uses |
CN113072617B (zh) * | 2021-03-30 | 2023-08-08 | 成都诺和晟泰生物科技有限公司 | 一种多肽化合物及其应用 |
CN113045625B (zh) * | 2021-03-30 | 2023-11-07 | 成都诺和晟泰生物科技有限公司 | 作为生长激素促分泌素受体激动剂的多肽及其应用 |
CN114805487B (zh) * | 2022-06-07 | 2024-03-12 | 成都诺和晟泰生物科技有限公司 | 一种多肽化合物及其应用 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5264565A (en) | 1991-01-22 | 1993-11-23 | Affymax Technologies, N.V. | Nucleic acid encoding the D2 /Ml chimeric receptor |
AU689181B2 (en) | 1993-12-23 | 1998-03-26 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
WO1995019567A1 (en) | 1994-01-13 | 1995-07-20 | The Trustees Of Columbia University In The City Of New York | Synthetic receptors, libraries and uses thereof |
SK284550B6 (sk) | 1994-09-27 | 2005-06-02 | Romano Deghenghi | Peptidy, farmaceutický prostriedok s ich obsahom a ich použitie |
US20020111461A1 (en) * | 1999-05-21 | 2002-08-15 | Todd C. Somers | Low molecular weight peptidomimetic growth hormone secretagogues |
US5798337A (en) * | 1994-11-16 | 1998-08-25 | Genentech, Inc. | Low molecular weight peptidomimetic growth hormone secretagogues |
US5776718A (en) * | 1995-03-24 | 1998-07-07 | Arris Pharmaceutical Corporation | Reversible protease inhibitors |
AU711104B2 (en) | 1995-06-22 | 1999-10-07 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
WO1997005252A2 (en) | 1995-07-26 | 1997-02-13 | Nps Pharmaceuticals, Inc. | Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors and the use of such compounds in the treatment of neurological disorders and diseases |
US5932548A (en) * | 1998-06-03 | 1999-08-03 | Deghenghi; Romano | Lysine containing peptides for treatment of heart disease |
US6124263A (en) * | 1998-11-16 | 2000-09-26 | Asta Medica Ag | Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
AU5671099A (en) * | 1998-08-14 | 2000-03-06 | The Administrators Of The Tulane Eductional Fund | Compounds having growth hormone releasing activity |
DE60035502T2 (de) | 1999-07-23 | 2008-03-20 | Kangawa, Kenji, Minoo | Neue peptide |
MXPA03000738A (es) | 2000-07-24 | 2003-06-04 | Ardana Bioscience Ltd | Antagonistas de grelina. |
TWI331922B (en) * | 2002-08-09 | 2010-10-21 | Ipsen Pharma Sas | Growth hormone releasing peptides |
WO2006045314A2 (en) | 2004-10-27 | 2006-05-04 | Gastrotech Pharma A/S | Use of a growth hormone secretatogue for increasing or maintaining lean body mass and/or for treatment of chronic obstructive pulmonary disease |
CA2625447C (en) * | 2005-09-29 | 2015-06-09 | Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. | Compositions and methods for stimulating gastrointestinal motility |
EP2012809B1 (de) * | 2006-03-10 | 2013-05-22 | Ipsen Pharma | Verwendung eines ghrelin-agonisten zur erhöhung der katabolischen wirkung einer glukokortikoidbehandlung |
TW200916113A (en) * | 2007-08-08 | 2009-04-16 | Sod Conseils Rech Applic | Method for inhibiting inflammation and pro-inflammatory cytokine/chemokine expression using a ghrelin analogue |
-
2003
- 2003-08-06 TW TW092121571A patent/TWI331922B/zh not_active IP Right Cessation
- 2003-08-08 BR BRPI0313273A patent/BRPI0313273B8/pt not_active IP Right Cessation
- 2003-08-08 DE DE60329923T patent/DE60329923D1/de not_active Expired - Lifetime
- 2003-08-08 CA CA2494300A patent/CA2494300C/en not_active Expired - Fee Related
- 2003-08-08 AR ARP030102883A patent/AR040965A1/es active IP Right Grant
- 2003-08-08 JP JP2004527871A patent/JP4365319B2/ja not_active Expired - Fee Related
- 2003-08-08 CN CN201210307885.0A patent/CN102850436B/zh not_active Expired - Fee Related
- 2003-08-08 PL PL373605A patent/PL212138B1/pl unknown
- 2003-08-08 EP EP03785034A patent/EP1542716B1/de not_active Expired - Lifetime
- 2003-08-08 CZ CZ20041254A patent/CZ20041254A3/cs unknown
- 2003-08-08 AT AT03785034T patent/ATE447411T1/de active
- 2003-08-08 BR BR122016015852A patent/BR122016015852B8/pt not_active IP Right Cessation
- 2003-08-08 DK DK03785034.4T patent/DK1542716T3/da active
- 2003-08-08 RU RU2005106236/04A patent/RU2323941C2/ru active
- 2003-08-08 EP EP09171176A patent/EP2130548A3/de not_active Withdrawn
- 2003-08-08 ES ES03785034T patent/ES2334223T3/es not_active Expired - Lifetime
- 2003-08-08 WO PCT/US2003/024834 patent/WO2004014415A1/en active IP Right Grant
- 2003-08-08 KR KR1020057001094A patent/KR100967572B1/ko active IP Right Grant
- 2003-08-08 CN CNA2007101279712A patent/CN101108875A/zh active Pending
- 2003-08-08 AU AU2003259062A patent/AU2003259062B2/en not_active Ceased
- 2003-08-08 CN CNA038186810A patent/CN1674927A/zh active Pending
- 2003-08-08 MX MXPA05000974A patent/MXPA05000974A/es active IP Right Grant
- 2003-08-08 SG SG2007033848A patent/SG177006A1/en unknown
- 2003-08-08 US US10/484,473 patent/US7456253B2/en active Active
-
2004
- 2004-12-27 IL IL165998A patent/IL165998A/en active IP Right Grant
-
2005
- 2005-01-13 NO NO20050205A patent/NO20050205L/no not_active Application Discontinuation
- 2005-08-03 HK HK05106694.1A patent/HK1072908A1/xx not_active IP Right Cessation
-
2007
- 2007-12-03 RU RU2007145026/04A patent/RU2007145026A/ru not_active Application Discontinuation
-
2008
- 2008-03-31 AR ARP080101348A patent/AR062801A2/es not_active Application Discontinuation
- 2008-06-09 US US12/157,224 patent/US8377865B2/en active Active
-
2009
- 2009-01-26 JP JP2009014262A patent/JP5025668B2/ja not_active Expired - Fee Related
-
2013
- 2013-01-04 US US13/734,314 patent/US8859729B2/en not_active Expired - Fee Related
-
2014
- 2014-10-09 US US14/510,188 patent/US9409948B2/en not_active Expired - Lifetime
-
2016
- 2016-07-07 US US15/203,956 patent/US20160311855A1/en not_active Abandoned
-
2017
- 2017-08-29 US US15/688,979 patent/US20170362275A1/en not_active Abandoned
-
2019
- 2019-09-25 US US16/581,960 patent/US20200017548A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE447411T1 (de) | Wachstumshormon freisetzende peptide | |
DK1478328T3 (da) | Bioaktive keratinpeptider | |
IL172403A0 (en) | D-amino acid peptides | |
DE602005015131D1 (de) | Interleukin-15-antagonistisches peptid | |
NO20025893L (no) | Veksthormon sekretagoga | |
DE60327407D1 (de) | Immunmodulierende peptide | |
AU2003290563A8 (en) | Leptin-related peptides | |
DE60122873D1 (de) | Therapeutische porenbildende peptide | |
GB2411404B (en) | Biologically active peptide conjugates | |
DE60336011D1 (de) | Proteaseresistentes ti-wachstumshormon freisetzendes hormon | |
IL172786A0 (en) | Biologically active peptide comprising tyrosyl-seryl-valine (ysv) | |
AU2003297317A8 (en) | Defensin-inducing peptides from fusobacterium | |
ATE445634T1 (de) | Antimikrobielle peptide | |
DE60334194D1 (de) | Transmembranes nfat-hemmendes peptid | |
ATE419271T1 (de) | Antimikrobielle peptide | |
EP1499635B8 (de) | Teneurin c-terminal assoziierte peptide und deren verwendungen | |
NO20032963D0 (no) | Peptidforbindelser | |
DK1230369T3 (da) | Polypeptidhormon phosphatonin | |
DK1625148T3 (da) | Peptidkompleks | |
GB0203552D0 (en) | Peptide growth factor | |
AU2003269153A1 (en) | Rfamide-related peptide precursor proteins and rfamide peptides | |
NO20050436D0 (no) | Beta-lagnedbrytende peptider | |
DE602004022136D1 (de) | Leukozyten stimulierende peptide | |
GB0202275D0 (en) | Peptide | |
AU2002364314A8 (en) | Growth hormone agonist peptides and their uses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |